Essential fatty acid deficiency prevention

Essential fatty acid deficiency prevention" is **not a molecular target, receptor, enzyme, transporter, or any specific biomolecule**. Instead, it refers to the clinical and nutritional strategies used to prevent a deficiency in essential fatty acids (EFAs), which are critical nutrients that humans must obtain from their diet because they cannot be synthesized endogenously[7][5]. The two primary EFAs are linoleic acid (an omega-6 fatty acid) and alpha-linolenic acid (an omega-3 fatty acid)[7][3]. Prevention of EFA deficiency involves ensuring adequate dietary intake of these fats—typically at least 2–4% of total calories from linoleic acid and about 10% of total calories from fat overall[5]. EFA deficiency can lead to symptoms such as rough, scaly skin and dermatitis[8][1], but this condition is rare in healthy individuals consuming a varied diet. Populations at risk include those with malabsorption syndromes or patients dependent on parenteral nutrition without sufficient lipid provision[5]. Prevention focuses on dietary counseling and appropriate use of oral or intravenous lipid sources when needed. Because "essential fatty acid deficiency prevention" describes an approach rather than a discrete molecular entity or drug target, it should not be classified as a therapeutic target for drug discovery purposes.